Trademark Search in Canada

Building Better Biologics

View On IC.GC.CA

REGISTERED

on 15 Apr 2010

Last Applicant/ Owned by

Zymeworks BC Inc.

Suite 800 - 114 East 4th AvenueVancouver

BRITISH COLUMBIA

V5T1G4

Serial Number

1436683 filed on 1^st May 2009

Registration Number

TMA764309 registered on 15^th Apr 2010

Registration expiry Date

15^th Apr 2035

Correspondent Address

GOWLING WLG (CANADA) LLP

550 BURRARD STREETSUITE 2300VANCOUVER

BRITISH COLUMBIA

V6C2B5

Building Better Biologics

Trademark usage description

chemical molecular analysis and product optimization provided to pharmaceutical, biotechnology and chemical industries using proprietary software and Read More

Classification Information

Class [042]
Chemical molecular analysis and product optimization provided to pharmaceutical, biotechnology and chemical industries using proprietary software and proprietary analytical tools and algorithms.

Classification kind code

Mark Details

Serial Number

1436683

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 55 on 15^th Apr 2010	Registered
Submitted for opposition 51 on 1^st Apr 2010	Allowance Notice Sent
Submitted for opposition 50 on 1^st Apr 2010	Allowed
Submitted for opposition 42 on 16^th Dec 2009	Advertised
Submitted for opposition 26 on 10^th Dec 2009	Approved
Submitted for opposition 27 on 21^st Oct 2009	Approval Notice Sent
Submitted for opposition 22 on 19^th Oct 2009	Search Recorded
Submitted for opposition 31 on 5^th May 2009	Formalized
Submitted for opposition 30 on 1^st May 2009	Filed
Submitted for opposition 1 on 1^st May 2009	Created

Building Better Biologics

Classification Information

Class [042]Chemical molecular analysis and product optimization provided to pharmaceutical, biotechnology and chemical industries using proprietary software and proprietary analytical tools and algorithms.

Classification kind code

Mark Details

Serial Number

Mark Type

Legal History

Class [042]
Chemical molecular analysis and product optimization provided to pharmaceutical, biotechnology and chemical industries using proprietary software and proprietary analytical tools and algorithms.